Sidra Medicine, a member of Qatar Foundation, has been awarded eleven grants valued at approximately QR 10.4 million from the Qatar National Research Fund (QNRF).

The grants will support both Sidra Medicines as well as Qatars national precision medicine program; enabling personalized clinical care for patients in Qatar and beyond.

Commenting on the grants, Acting Chief Research Officer, Sidra Medicine, Dr. Khalid Fakhro said: "Over the past four years, Sidra Medicines research department has been awarded over 35 grants from the Qatar National Research Fund. This is testament to the foundational role Sidra Medicine is playing in expanding Qatars research capacity and knowledge base. Many of our grants are tied to addressing a real clinical or research challenges that can positively impact patient outcomes."

The grants are under four QNRF streams: the National Priorities Research Program Cycle 12; Path Towards Precision Medicine Cycle 3; Conference and Workshop Sponsorship Program Cycle 17 and the Researchers Exchange and Mobility Program.

Key projects awarded include biomedical and health programs that will allow clinicians to select suitable treatments for specific infectious diseases; how stem cells can be used as a therapeutic tool for type 1 diabetes as well as a precision medicine approach to prevent diabetic complications in affected Qatari individuals. Grants were also awarded to projects that will map the genetic causes of infertility and genome editing for cell-based cancer immunotherapy.

Source: Qatar News Agency
Image credit: Sidra Medicine

Follow us on our social media channels: @ILQlive @ILQlive @ILoveQtr ILoveQatar

Sumaica Asad

Start a discussion